Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rush

Showing results (121-130 of 565) with videos related to

Pageof 57
Sort By:
Neuropsychiatric Disease and Treatment|April 1, 2024
Psychometric evaluation and linking of the PHQ-9, QIDS-C, and VQIDS-C in a real-world population with major depressive disorderEmily O C Palmer, Sheryl Ker, Miguel E Rentería, et al.
Journal of Psychoactive Drugs|September 20, 2022
Scoping Review of Experiential Measures from Psychedelic Research and Clinical TrialsZachary Herrmann, Mitch Earleywine, Joseph De Leo, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|July 17, 2013
Screening for postnatal depression in Chinese-speaking women using the Hong Kong translated version of the Edinburgh Postnatal Depression ScaleHelen Chen, Dianne Bautista, Ying Chia Ch'ng, et al.
Journal of Psychiatric Research|May 24, 2006
Clinical vs. self-report versions of the quick inventory of depressive symptomatology in a public sector sampleIra H Bernstein, A John Rush, Thomas J Carmody, et al.
Addiction (Abingdon, England)|July 14, 2019
Response to commentariesJohn Marsden, Betty Tai, Robert Ali, et al.
The Primary Care Companion for CNS Disorders|November 17, 2022
Vaccine-Induced Psychosis as an Etiology to Consider in the Age of COVID-19Helene Alphonso, Dustin DeMoss, Cheryl Hurd, et al.
Journal of Psychopharmacology (Oxford, England)|August 9, 2024
Evidence-based guidelines for the interpretation of the 9-item Concise Health Risk Tracking - Self-Report (CHRT-SR<sub>9</sub>) measure of suicidal riskKarabi Nandy, Rajesh Ranjan Nandy, A John Rush, et al.
Biological Psychiatry|September 17, 2005
Use of bupropion in combination with serotonin reuptake inhibitorsSidney Zisook, A John Rush, Barbara R Haight, et al.
Contemporary Clinical Trials|April 20, 2005
Quality improvement methods as applied to a multicenter effectiveness trial--STAR*DDiane Warden, A John Rush, Madhukar Trivedi, et al.
Neuropsychiatric Disease and Treatment|December 27, 2007
Item Response Analysis of the Inventory of Depressive SymptomatologyIra H Bernstein, A John Rush, Carmody J Thomas, et al.
Pageof 57

Showing results (121-130 of 565) with videos related to

Sort By:
Pageof 57
Neuropsychiatric Disease and Treatment|April 1, 2024
Psychometric evaluation and linking of the PHQ-9, QIDS-C, and VQIDS-C in a real-world population with major depressive disorderEmily O C Palmer, Sheryl Ker, Miguel E Rentería, et al.
Journal of Psychoactive Drugs|September 20, 2022
Scoping Review of Experiential Measures from Psychedelic Research and Clinical TrialsZachary Herrmann, Mitch Earleywine, Joseph De Leo, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|July 17, 2013
Screening for postnatal depression in Chinese-speaking women using the Hong Kong translated version of the Edinburgh Postnatal Depression ScaleHelen Chen, Dianne Bautista, Ying Chia Ch'ng, et al.
Journal of Psychiatric Research|May 24, 2006
Clinical vs. self-report versions of the quick inventory of depressive symptomatology in a public sector sampleIra H Bernstein, A John Rush, Thomas J Carmody, et al.
Addiction (Abingdon, England)|July 14, 2019
Response to commentariesJohn Marsden, Betty Tai, Robert Ali, et al.
The Primary Care Companion for CNS Disorders|November 17, 2022
Vaccine-Induced Psychosis as an Etiology to Consider in the Age of COVID-19Helene Alphonso, Dustin DeMoss, Cheryl Hurd, et al.
Journal of Psychopharmacology (Oxford, England)|August 9, 2024
Evidence-based guidelines for the interpretation of the 9-item Concise Health Risk Tracking - Self-Report (CHRT-SR<sub>9</sub>) measure of suicidal riskKarabi Nandy, Rajesh Ranjan Nandy, A John Rush, et al.
Biological Psychiatry|September 17, 2005
Use of bupropion in combination with serotonin reuptake inhibitorsSidney Zisook, A John Rush, Barbara R Haight, et al.
Contemporary Clinical Trials|April 20, 2005
Quality improvement methods as applied to a multicenter effectiveness trial--STAR*DDiane Warden, A John Rush, Madhukar Trivedi, et al.
Neuropsychiatric Disease and Treatment|December 27, 2007
Item Response Analysis of the Inventory of Depressive SymptomatologyIra H Bernstein, A John Rush, Carmody J Thomas, et al.
Pageof 57